Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01488240

The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effects (good or bad) of pulsed dye laser treatment in burn scar height, texture, redness and pliability in acute burn injury.

Detailed description

While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials. Laser therapy can be quite expensive when compared to other treatment modalities for burn scars, and while promising, its true usefulness has yet to be conclusively demonstrated. For this reason, our research group is proposing the commencement of two randomized controlled trial pilot studies assessing the effects of pulsed dye laser (PDL) on burn scars. The objectives of this project will be to determine the effectiveness of pulsed dye laser therapy on burn scar vascularity, pliability, height and texture. It has been hypothesized that the PDL works on acute injury to decrease scar formation, and the fractional laser works on scar that is quiescent to promote remodelling. Therefore the investigators are proposing to study both acute injury and late burn scars. This project will compare the effects of each laser type, and will either help support or refute the assertion that laser therapy can be used to improve burn scars. Objectives: To determine the benefit of pulsed dye laser treatment in improving burn scar height, texture, vascularity and pliability in acute burn injury.

Conditions

Interventions

TypeNameDescription
PROCEDUREpulsed dye laserlaser energy

Timeline

Start date
2012-11-01
Primary completion
2026-06-01
Completion
2027-06-01
First posted
2011-12-08
Last updated
2024-12-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01488240. Inclusion in this directory is not an endorsement.